Pure Global

Anti beta 2 Glycoprotein 1 Screen-"Anti beta 2 Glycoprotein 1 Screen is an indirect enzymelinked immunosorbent assay kit designed for the quantitative measurement of IgG or IgM class antibodies directed against the β2 - India CDSCO Medical Device Registration

Anti beta 2 Glycoprotein 1 Screen-"Anti beta 2 Glycoprotein 1 Screen is an indirect enzymelinked immunosorbent assay kit designed for the quantitative measurement of IgG or IgM class antibodies directed against the β2 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000352_9d45c150279c7c02335dd0c475c6f0ab_4686ef3bcf162b00d13fa56f208373cc. This device is marketed under the brand name c-ANCA. The license holder is Amindo Biologics Pvt. Ltd, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Anti beta 2 Glycoprotein 1 Screen-"Anti beta 2 Glycoprotein 1 Screen is an indirect enzymelinked immunosorbent assay kit designed for the quantitative measurement of IgG or IgM class antibodies directed against the β2
UID: IMP/IVD/2019/000352_9d45c150279c7c02335dd0c475c6f0ab_4686ef3bcf162b00d13fa56f208373cc

Brand Name

c-ANCA

Device Class

Class B

Approving Authority

CDSCO

Product Information

Glycoprotein 1 in human serum or plasma. Anti beta 2 Glycoprotein 1 Screen is intended for laboratory use only."

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing